Empowerment Intervention for Persons With Young Onset Dementia
- Conditions
- DementiaEmpowerment
- Interventions
- Other: Empowerment intervention
- Registration Number
- NCT02937883
- Lead Sponsor
- Radboud University Medical Center
- Brief Summary
The purpose of this study is to evaluate the effects of an empowerment intervention for community-dwelling persons with young onset dementia and their informal caregivers.
- Detailed Description
This study focuses on the evaluation of an empowerment intervention developed for persons with young onset dementia and their informal caregivers. The empowerment intervention focuses on current capacities, maintenance of autonomy, and increasing the opportunities to feel useful. This pragmatic cluster randomized controlled trial aims to investigate (1) the effectiveness of the intervention concerning participants' well-being, quality of life, and behavioral issues, (2) the effect of the intervention on the informal caregivers' sense of competence and perceived distress, and (3) the impact of the intervention on healthcare costs. Furthermore, the investigators aim to study the feasibility of the intervention to frame an implementation strategy.
Participants in the intervention group will receive the intervention for 5 months. Participants of the control group receive care as usual.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 60
- Diagnosed with dementia before the age of 65
- Living at home (community-dwelling)
- Dementia is caused by Down's syndrome, Huntington's disease, HIV or alcohol-related dementia.
- Limited contact between the person with dementia and the informal caregiver (<3 times a week)
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description empowerment intervention Empowerment intervention Empowerment intervention
- Primary Outcome Measures
Name Time Method Changes in self-management abilities 5 months (Self-Management Ability Scale (SMAS))
- Secondary Outcome Measures
Name Time Method Changes in disability 5 months (Interview for Deterioration in Daily living activities in Dementia (IDDD))
Changes in quality of life 5 months (Quality of life - Alzheimer Disease scale (QOL-AD))
Changes in neuropsychiatric symptoms Questionnaire 5 months (Neuropsychiatric Inventory (NPI-Q))
Caregiver measures:Competence ( 5 months Short Sense of Competence Questionnaire (SSCQ))
Changes in apathy 5 months (abbreviated Apathy Evaluation Scale (AES-10))
Caregiver measures: Emotional distress 5 months (NPI-Q distress score)
Trial Locations
- Locations (1)
Florence
🇳🇱Den Haag, Netherlands